A multi-dataset time-reversal approach to clinical trial placebo response and the relationship to natural variability in epilepsy

Typical RR50s of clinical trials can be reproduced using the natural variability of epilepsy as a substrate across multiple datasets. Therefore, the placebo response in epilepsy clinical trials may be attributable almost entirely to this variability, rather than the “placebo effect”.